On January 14th, 2025, InductiveHealth and Envision Technology Partners (“Envision”) completed an exciting transaction whereby InductiveHealth (and its private equity partner Diversis) acquired Envision. Envision is a Public Health software development and consulting firm. Since 2001, Envision has been offering an enterprise-level public health product suite as well as custom software development and consulting services to federal, state, and local government agencies around the country and across the globe.
We are currently seeking a Senior Accessibility Software Engineer for our immunization information system software products to join our expanding national team with headquarters in Greenwood Village, CO. The ideal candidate is an experienced software engineer who understand 508 compliance and updating software for accessibility purposes. They will possess a desire to help the world be a healthier place to live in and a keen interest in public health technology. This is a contract-to-hire position where once you are converted into a permanent role, you’ll enjoy a competitive salary and benefits package (medical, dental, vision insurance, long term disability, group life, 401K, etc.), a casual work environment, and flexible PTO. You must be eligible to work in the U.S. without sponsorship.
This position reports to: Vice President of Software Development
Top Skills
Similar Jobs
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
